Piedmont Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Piedmont Investment Advisors's AMGN Position: Q2 2020 in Review
Piedmont Investment Advisors sold out of Amgen (AMGN) in Q2 2020, closing a stake of 86,895 shares — an estimated $17.6M sold.
Piedmont Investment Advisors first reported a position in AMGN in Q2 2013 and held it in 28 quarters. The position peaked at $33.9M in Q3 2017. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.
- Piedmont Investment Advisors reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
- Piedmont Investment Advisors sold 86,895 Amgen shares in Q2 2020, an estimated $17.6M.
- Piedmont Investment Advisors first reported a position in Amgen in Q2 2013 and held it in 28 quarters.
- Piedmont Investment Advisors's Amgen position peaked at $33.9M in Q3 2017.
- 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.
Based on Piedmont Investment Advisors's 13F filing for Q2 2020.